Matches in Wikidata for { <http://www.wikidata.org/entity/Q33829749> ?p ?o ?g. }
- Q33829749 description "2014 nî lūn-bûn" @default.
- Q33829749 description "2014 թուականի Մայիսին հրատարակուած գիտական յօդուած" @default.
- Q33829749 description "2014 թվականի մայիսին հրատարակված գիտական հոդված" @default.
- Q33829749 description "2014年の論文" @default.
- Q33829749 description "2014年論文" @default.
- Q33829749 description "2014年論文" @default.
- Q33829749 description "2014年論文" @default.
- Q33829749 description "2014年論文" @default.
- Q33829749 description "2014年論文" @default.
- Q33829749 description "2014年论文" @default.
- Q33829749 description "2014年论文" @default.
- Q33829749 description "2014年论文" @default.
- Q33829749 description "2014年论文" @default.
- Q33829749 description "2014年论文" @default.
- Q33829749 description "2014年论文" @default.
- Q33829749 description "2014년 논문" @default.
- Q33829749 description "article científic" @default.
- Q33829749 description "article scientific" @default.
- Q33829749 description "article scientifique (publié 2014)" @default.
- Q33829749 description "articol științific" @default.
- Q33829749 description "articolo scientifico" @default.
- Q33829749 description "artigo científico (publicado na 2014)" @default.
- Q33829749 description "artigo científico (publicado na 2014)" @default.
- Q33829749 description "artigo científico" @default.
- Q33829749 description "artikull shkencor" @default.
- Q33829749 description "artikulong pang-agham" @default.
- Q33829749 description "artykuł naukowy" @default.
- Q33829749 description "artículo científico publicado en 2014" @default.
- Q33829749 description "artículu científicu espublizáu en 2014" @default.
- Q33829749 description "bilimsel makale" @default.
- Q33829749 description "bài báo khoa học" @default.
- Q33829749 description "mokslinis straipsnis" @default.
- Q33829749 description "naučni članak" @default.
- Q33829749 description "scienca artikolo" @default.
- Q33829749 description "scientific article" @default.
- Q33829749 description "teaduslik artikkel" @default.
- Q33829749 description "tieteellinen artikkeli" @default.
- Q33829749 description "tudományos cikk" @default.
- Q33829749 description "vedecký článok" @default.
- Q33829749 description "vetenskaplig artikel" @default.
- Q33829749 description "videnskabelig artikel (udgivet 2014)" @default.
- Q33829749 description "vitenskapelig artikkel" @default.
- Q33829749 description "vitskapeleg artikkel" @default.
- Q33829749 description "vědecký článek" @default.
- Q33829749 description "wetenschappelijk artikel" @default.
- Q33829749 description "wissenschaftlicher Artikel" @default.
- Q33829749 description "επιστημονικό άρθρο" @default.
- Q33829749 description "мақолаи илмӣ" @default.
- Q33829749 description "мақолаи илмӣ" @default.
- Q33829749 description "наукова стаття, опублікована в травні 2014" @default.
- Q33829749 description "научна статия" @default.
- Q33829749 description "научная статья" @default.
- Q33829749 description "научни чланак" @default.
- Q33829749 description "научни чланак" @default.
- Q33829749 description "מאמר מדעי" @default.
- Q33829749 description "سائنسی مضمون" @default.
- Q33829749 description "مقالة علمية" @default.
- Q33829749 description "مقالهٔ علمی" @default.
- Q33829749 description "২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33829749 description "บทความทางวิทยาศาสตร์" @default.
- Q33829749 description "სამეცნიერო სტატია" @default.
- Q33829749 name "Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR" @default.
- Q33829749 name "Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR" @default.
- Q33829749 name "Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR" @default.
- Q33829749 type Item @default.
- Q33829749 label "Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR" @default.
- Q33829749 label "Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR" @default.
- Q33829749 label "Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR" @default.
- Q33829749 prefLabel "Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR" @default.
- Q33829749 prefLabel "Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR" @default.
- Q33829749 prefLabel "Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR" @default.
- Q33829749 P1433 Q33829749-41727E83-CC3D-42A1-9C12-CB4865B9179C @default.
- Q33829749 P1476 Q33829749-1696499B-105B-4993-B5C2-C0AB1C267A80 @default.
- Q33829749 P2093 Q33829749-0AF94175-1A1C-4811-99AB-FE4A90AD9AE8 @default.
- Q33829749 P2093 Q33829749-3834FB9E-6D22-4C0D-8FD8-E8B2C435C8BB @default.
- Q33829749 P2093 Q33829749-8936B212-43D9-4104-8A41-C2563E4FC17D @default.
- Q33829749 P2093 Q33829749-9CB6E263-4192-45F7-BA13-67B2AEF92B7D @default.
- Q33829749 P2093 Q33829749-A28F6ACC-6C26-4F78-83FB-CB86AC15E44D @default.
- Q33829749 P2093 Q33829749-C6C02C32-B33F-4E50-9E77-42CD151CBB8C @default.
- Q33829749 P2093 Q33829749-CBDD5590-8F80-450B-AFDC-8468C35E0C53 @default.
- Q33829749 P2093 Q33829749-DD1B7145-F741-4A1A-9CDD-7DC1AAB29457 @default.
- Q33829749 P2093 Q33829749-FB60A7AC-6C04-45E7-A477-3602004991BC @default.
- Q33829749 P304 Q33829749-BE7C831C-9D6E-4F96-A153-323C58FE6FAD @default.
- Q33829749 P31 Q33829749-3E7F6857-14DE-4E5D-B011-D5AF29A7F935 @default.
- Q33829749 P356 Q33829749-FDDDADA7-8140-4442-906A-C8D1D1AAF967 @default.
- Q33829749 P433 Q33829749-605AD004-F265-4BE6-9B71-35D3FC8FDBA5 @default.
- Q33829749 P478 Q33829749-880EA92E-3615-4E4C-B5AA-51D66ABC4F6A @default.
- Q33829749 P50 Q33829749-9E4A4F5B-A90D-4727-AA74-EFF592517CE2 @default.
- Q33829749 P577 Q33829749-50500835-8361-440A-98B1-25FDCE44384D @default.
- Q33829749 P5875 Q33829749-02AECA1E-59AA-470E-86A7-CBEDCFB20FED @default.
- Q33829749 P698 Q33829749-D27352A7-022B-408D-A147-4AC989B81679 @default.
- Q33829749 P932 Q33829749-138B491C-21B2-45FC-8ECC-A805DBB0B93B @default.
- Q33829749 P356 THEONCOLOGIST.2013-0419 @default.
- Q33829749 P698 24868099 @default.
- Q33829749 P1433 Q2122327 @default.
- Q33829749 P1476 "Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR" @default.
- Q33829749 P2093 "Dae Ho Lee" @default.
- Q33829749 P2093 "Dan Massey" @default.
- Q33829749 P2093 "Jin Seok Ahn" @default.
- Q33829749 P2093 "Jong-Mu Sun" @default.